ADA: Bayer builds its case for potential kidney disease blockbuster Kerendia

ADA: Bayer builds its case for potential kidney disease blockbuster Kerendia

Source: 
Fierce Pharma
snippet: 

Chronic kidney disease (CKD) often moves silently and unpredictably. It is one of the most common complications stemming from diabetes, with up to 40% of all diabetics ultimately battling the complication.